ORCID and DataCite

por Brase, Jan
Publicado 2011

Serum microRNAs as non-invasive biomarkers for cancer

por Brase, Jan C, Wuttig, Daniela, Kuner, Ruprecht, Sültmann, Holger
Publicado 2010

From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis

por Brase, Jan C., Kronenwett, Ralf, Petry, Christoph, Denkert, Carsten, Schmidt, Marcus
Publicado 2013

Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer

por Gade, Stephan, Porzelius, Christine, Fälth, Maria, Brase, Jan C, Wuttig, Daniela, Kuner, Ruprecht, Binder, Harald, Sültmann, Holger, Beißbarth, Tim
Publicado 2011

Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification

por Brase, Jan C, Mannsperger, Heiko, Fröhlich, Holger, Gade, Stephan, Schmidt, Christian, Wiemann, Stefan, Beissbarth, Tim, Schlomm, Thorsten, Sültmann, Holger, Korf, Ulrike
Publicado 2010

Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sections

por Müller, Berit Maria, Brase, Jan C, Haufe, Franziska, Weber, Karsten E, Budzies, Jan, Petry, Christoph, Prinzler, Judith, Kronenwett, Ralf, Dietel, Manfred, Denkert, Carsten
Publicado 2012

ERG Induces Epigenetic Activation of Tudor Domain-Containing Protein 1 (TDRD1) in ERG Rearrangement-Positive Prostate Cancer

por Kacprzyk, Lukasz A., Laible, Mark, Andrasiuk, Tatjana, Brase, Jan C., Börno, Stefan T., Fälth, Maria, Kuner, Ruprecht, Lehrach, Hans, Schweiger, Michal R., Sültmann, Holger
Publicado 2013

A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue

por Hellwinkel, Olaf J. C., Sellier, Christina, Sylvester, Yu-Mi Jessica, Brase, Jan C., Isbarn, Hendrik, Erbersdobler, Andreas, Steuber, Thomas, Sültmann, Holger, Schlomm, Thorsten, Wagner, Christina
Publicado 2013

Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia

por Jarius, Sven, Martínez-García, Pedro, Hernandez, Adelaida León, Brase, Jan Christoph, Borowski, Kathrin, Regula, Jens Ulrich, Meinck, Hans Michael, Stöcker, Winfried, Wildemann, Brigitte, Wandinger, Klaus-Peter
Publicado 2013

Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer

por Poremba, Christopher, Uhlendorff, Jennifer, Pfitzner, Berit M., Hennig, Guido, Bohmann, Kerstin, Bojar, Hans, Krenn, Veit, Brase, Jan C., Haufe, Franziska, Averdick, Manuela, Dietel, Manfred, Kronenwett, Ralf, Denkert, Carsten
Publicado 2014

Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients

por Blank, Patricia R., Filipits, Martin, Dubsky, Peter, Gutzwiller, Florian, Lux, Michael P., Brase, Jan C., Weber, Karsten E., Rudas, Margaretha, Greil, Richard, Loibl, Sibylle, Szucs, Thomas D., Kronenwett, Ralf, Schwenkglenks, Matthias, Gnant, Michael
Publicado 2014

Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (C...

por Tawbi, Hussein A, Robert, Caroline, Brase, Jan C, Gusenleitner, Daniel, Gasal, Eduard, Garrett, James, Savchenko, Alexander, Görgün, Güllü, Flaherty, Keith T, Ribas, Antoni, Dummer, Reinhard, Schadendorf, Dirk, Long, Georgina V, Nathan, Paul D, Ascierto, Paolo A
Publicado 2022

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling

por Brase, Jan C, Johannes, Marc, Mannsperger, Heiko, Fälth, Maria, Metzger, Jennifer, Kacprzyk, Lukasz A, Andrasiuk, Tatjana, Gade, Stephan, Meister, Michael, Sirma, Hüseyin, Sauter, Guido, Simon, Ronald, Schlomm, Thorsten, Beißbarth, Tim, Korf, Ulrike, Kuner, Ruprecht, Sültmann, Holger
Publicado 2011

HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer

por Denkert, Carsten, Huober, Jens, Loibl, Sibylle, Prinzler, Judith, Kronenwett, Ralf, Darb-Esfahani, Silvia, Brase, Jan C, Solbach, Christine, Mehta, Keyur, Fasching, Peter A, Sinn, Bruno V, Engels, Knut, Reinisch, Mattea, Hansmann, Martin-Leo, Tesch, Hans, von Minckwitz, Gunter, Untch, Michael
Publicado 2013

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2− breast cancer patients: results from the GEICAM 9906 trial

por Martin, Miguel, Brase, Jan C, Calvo, Lourdes, Krappmann, Kristin, Ruiz-Borrego, Manuel, Fisch, Karin, Ruiz, Amparo, Weber, Karsten E, Munarriz, Blanca, Petry, Christoph, Rodriguez, Cesar A, Kronenwett, Ralf, Crespo, Carmen, Alba, Emilio, Carrasco, Eva, Casas, Maribel, Caballero, Rosalia, Rodriguez-Lescure, Alvaro
Publicado 2014

Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test

por Kronenwett, Ralf, Bohmann, Kerstin, Prinzler, Judith, Sinn, Bruno V, Haufe, Franziska, Roth, Claudia, Averdick, Manuela, Ropers, Tanja, Windbergs, Claudia, Brase, Jan C, Weber, Karsten E, Fisch, Karin, Müller, Berit M, Schmidt, Marcus, Filipits, Martin, Dubsky, Peter, Petry, Christoph, Dietel, Manfred, Denkert, Carsten
Publicado 2012

Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative b...

por Martin, Miguel, Brase, Jan C., Ruiz, Amparo, Prat, Aleix, Kronenwett, Ralf, Calvo, Lourdes, Petry, Christoph, Bernard, Philip S., Ruiz-Borrego, Manuel, Weber, Karsten E., Rodriguez, César A., Alvarez, Isabel M., Segui, Miguel A., Perou, Charles M., Casas, Maribel, Carrasco, Eva, Caballero, Rosalía, Rodriguez-Lescure, Alvaro
Publicado 2016

Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600–Mutant Unresectable or Metastatic Melanoma

por Dummer, Reinhard, Long, Georgina V., Robert, Caroline, Tawbi, Hussein A., Flaherty, Keith T., Ascierto, Paolo A., Nathan, Paul D., Rutkowski, Piotr, Leonov, Oleg, Dutriaux, Caroline, Mandalà, Mario, Lorigan, Paul, Ferrucci, Pier Francesco, Grob, Jean Jacques, Meyer, Nicolas, Gogas, Helen, Stroyakovskiy, Daniil, Arance, Ana, Brase, Jan C., Green, Steven, Haas, Tomas, Masood, Aisha, Gasal, Eduard, Ribas, Antoni, Schadendorf, Dirk
Publicado 2022

Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib

por Brase, Jan C., Walter, Robert F.H., Savchenko, Alexander, Gusenleitner, Daniel, Garrett, James, Schimming, Tobias, Varaljai, Renata, Castelletti, Deborah, Kim, Ju, Dakappagari, Naveen, Schultz, Ken, Robert, Caroline, Long, Georgina V., Nathan, Paul D., Ribas, Antoni, Flaherty, Keith T., Karaszewska, Boguslawa, Schachter, Jacob, Sucker, Antje, Schmid, Kurt W., Zimmer, Lisa, Livingstone, Elisabeth, Gasal, Eduard, Schadendorf, Dirk, Roesch, Alexander
Publicado 2021

Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma

por Váraljai, Renáta, Zimmer, Lisa, Al-Matary, Yahya, Kaptein, Paulien, Albrecht, Lea J., Shannan, Batool, Brase, Jan C., Gusenleitner, Daniel, Amaral, Teresa, Wyss, Nina, Utikal, Jochen, Flatz, Lukas, Rambow, Florian, Reinhardt, Hans Christian, Dick, Jenny, Engel, Daniel R., Horn, Susanne, Ugurel, Selma, Sondermann, Wiebke, Livingstone, Elisabeth, Sucker, Antje, Paschen, Annette, Zhao, Fang, Placke, Jan M., Klose, Jasmin M., Fendler, Wolfgang P., Thommen, Daniela S., Helfrich, Iris, Schadendorf, Dirk, Roesch, Alexander
Publicado 2023